|
TRDA Entrada Therapeutics Inc 1689375 |
| Balance Sheet |
|
Current Assets
|
465,335,000 |
|
Assets
|
554,590,000 |
|
Current Liabilities
|
70,603,000 |
|
Liabilities
|
132,143,000 |
|
Equity
|
422,447,000 |
|
Shares Out
|
37,200,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-9,952,000 |
|
Investing Cash Flow
|
-81,163,000 |
| Market Analysis |
Market Cap
|
535,115,391 |
|
Price
|
12.69 |
|
BVPS
|
11.36 |
|
PB
|
1.11 |
|
EPS
|
2.96 |
|
PE
|
4.86 |
|
PS
|
6.84 |
|
FCF
|
-91,115,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TRDA documents filed with the SEC.
TRDA Filings
Clear
